Skip to main content
Erschienen in: Urolithiasis 6/2019

18.02.2019 | Original Paper

Protective effect of salvianolic acid B against oxidative injury associated with cystine stone formation

verfasst von: Zhang Yifan, Xu Luwei, Liang Kai, Zhou Liuhua, Ge Yuzheng, Jia Ruipeng

Erschienen in: Urolithiasis | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the role of oxidative stress in cystine crystal formation and whether salvianolic acid B, a natural antioxidant, could prevent cystine-mediated oxidative injury in vivo and in vitro. The levels of oxidative stress and antioxidase activity in cystine stone patients were assessed. Then, the oxidative stress exerted by cystine on human kidney-2 (HK-2) cell viability and biochemical parameters including antioxidase activity and antioxidant protein expression were evaluated, and the protective action of salvianolic acid B was also examined. Finally, salvianolic acid B was tested to determine whether it could prevent or reduce renal crystal formation in Slc7a9 knockout mice. The activity levels of superoxide dismutase (SOD) and glutathione peroxidase (GPx) were decreased, and the amount of malondialdehyde (MDA) was increased in patients with cystine stones compared with people without cystine stones (p < 0.05). Significant reductions in cell viability, antioxidase activity and antioxidant protein expression levels were found in the cystine group compared with controls. However, such oxidative injuries were prevented by salvianolic acid B. In the animal study, loose crystals with white spots were seen in the renal parenchyma, bilateral renal pelvis and bladders in the Slc7a9 knockout group. In contrast, no renal crystals were seen in the control group, and markedly fewer crystals with significantly higher antioxidase activity and diminished oxidative stress were detected in the salvianolic acid B group. Cystine cytotoxicity in vitro and cystine stone formation in vivo were associated with oxidative stress, and salvianolic acid B could protect against cystine stone-induced injury.
Literatur
1.
Zurück zum Zitat Claes DJ, Jackson E (2012) Cystinuria: mechanisms and management. Pediatr Nephrol 27(11):2031PubMedCrossRef Claes DJ, Jackson E (2012) Cystinuria: mechanisms and management. Pediatr Nephrol 27(11):2031PubMedCrossRef
2.
Zurück zum Zitat Elmacı AM, Ece A, Akın F (2014) Pediatric urolithiasis: metabolic risk factors and follow-up results in a Turkish region with endemic stone disease. Urolithiasis 42(5):421PubMedCrossRef Elmacı AM, Ece A, Akın F (2014) Pediatric urolithiasis: metabolic risk factors and follow-up results in a Turkish region with endemic stone disease. Urolithiasis 42(5):421PubMedCrossRef
3.
Zurück zum Zitat Knoll T, Zöllner A, Wendt-Nordahl G et al (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20(1):19PubMedCrossRef Knoll T, Zöllner A, Wendt-Nordahl G et al (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20(1):19PubMedCrossRef
4.
Zurück zum Zitat Andreassen KH, Pedersen KV, Osther SS et al (2016) How should patients with cystine stone disease be evaluated and treated in the twenty-first century? Urolithiasis 44(1):65PubMedCrossRef Andreassen KH, Pedersen KV, Osther SS et al (2016) How should patients with cystine stone disease be evaluated and treated in the twenty-first century? Urolithiasis 44(1):65PubMedCrossRef
6.
Zurück zum Zitat Chi T, Taylor E, Stoller ML (2014) Treating the cystine stone former presents a singular clinical challenge. Trans Androl Urol 3(3):234 Chi T, Taylor E, Stoller ML (2014) Treating the cystine stone former presents a singular clinical challenge. Trans Androl Urol 3(3):234
7.
Zurück zum Zitat Erickson SB, Vrtiska TJ, Canzanello VJ et al (2011) Cystone for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers. Urol Res 39(3):197PubMedCrossRef Erickson SB, Vrtiska TJ, Canzanello VJ et al (2011) Cystone for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers. Urol Res 39(3):197PubMedCrossRef
8.
Zurück zum Zitat Purohit RS, Stoller ML (2004) Stone clustering of patients with cystine urinary stone formation. Urology 63(4):630PubMedCrossRef Purohit RS, Stoller ML (2004) Stone clustering of patients with cystine urinary stone formation. Urology 63(4):630PubMedCrossRef
9.
Zurück zum Zitat Pietrow PK, Auge BK, Weizer AZ et al (2003) Durability of the medical management of cystinuria. J Urol 169:68–70PubMedCrossRef Pietrow PK, Auge BK, Weizer AZ et al (2003) Durability of the medical management of cystinuria. J Urol 169:68–70PubMedCrossRef
10.
Zurück zum Zitat Mårtensson J, Denneberg T, Lindell A et al (1990) Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients. [J]. Kidney Int 37(1):143–149PubMedCrossRef Mårtensson J, Denneberg T, Lindell A et al (1990) Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients. [J]. Kidney Int 37(1):143–149PubMedCrossRef
11.
Zurück zum Zitat Martins MC, Meyers AA, Whalley NA et al (2002) Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine. J Urol 167(1):317–321PubMedCrossRef Martins MC, Meyers AA, Whalley NA et al (2002) Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine. J Urol 167(1):317–321PubMedCrossRef
12.
Zurück zum Zitat Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30(1):35–47PubMedCrossRef Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30(1):35–47PubMedCrossRef
13.
Zurück zum Zitat Nishizawa-Yokoi A, Tainaka H, Yoshida E et al (2010) The 26S proteasome function and Hsp90 activity involved in the regulation of HsfA2 expression in response to oxidative stress. Plant Cell Physiol 51(3):486–496PubMedCrossRef Nishizawa-Yokoi A, Tainaka H, Yoshida E et al (2010) The 26S proteasome function and Hsp90 activity involved in the regulation of HsfA2 expression in response to oxidative stress. Plant Cell Physiol 51(3):486–496PubMedCrossRef
14.
Zurück zum Zitat Dantas AS, Mj ARC, Felipe MS et al (2008) Oxidative stress response in Paracoccidioides brasiliensis: assessing catalase and cytochrome c peroxidase. Mycol Res 112(6):747–756PubMedCrossRef Dantas AS, Mj ARC, Felipe MS et al (2008) Oxidative stress response in Paracoccidioides brasiliensis: assessing catalase and cytochrome c peroxidase. Mycol Res 112(6):747–756PubMedCrossRef
15.
Zurück zum Zitat Thomas K, Wong K, Withington J, Bultitude M, Doherty A (2014) Cystinuria-a urologist’s perspective. Nat Rev Urol 11(5):270–277PubMedCrossRef Thomas K, Wong K, Withington J, Bultitude M, Doherty A (2014) Cystinuria-a urologist’s perspective. Nat Rev Urol 11(5):270–277PubMedCrossRef
16.
Zurück zum Zitat Nancollas GH, Henneman ZJ (2010) Calcium oxalate: calcium phosphate transformations. Urolithiasis 38(4):277–280 Nancollas GH, Henneman ZJ (2010) Calcium oxalate: calcium phosphate transformations. Urolithiasis 38(4):277–280
17.
Zurück zum Zitat Saravakos P, Kokkinou V, Giannatos E (2014) Cystinuria: current diagnosis and management. Urology 83(4):693–699PubMedCrossRef Saravakos P, Kokkinou V, Giannatos E (2014) Cystinuria: current diagnosis and management. Urology 83(4):693–699PubMedCrossRef
18.
Zurück zum Zitat Khaskhali MH, Byer KJ, Khan SR (2009) The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury. Urolithiasis 37(1):1 Khaskhali MH, Byer KJ, Khan SR (2009) The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury. Urolithiasis 37(1):1
19.
Zurück zum Zitat Hirose M, Yasui T, Okada A, Hamamoto S, Shimizu H, Itoh Y (2009) Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney: original article: laboratory investigation. Int J Urol 17(1):83–92PubMedCrossRef Hirose M, Yasui T, Okada A, Hamamoto S, Shimizu H, Itoh Y (2009) Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney: original article: laboratory investigation. Int J Urol 17(1):83–92PubMedCrossRef
20.
Zurück zum Zitat Huang HS, Ma MC (2015) High sodium-induced oxidative stress and poor anticrystallization defense aggravate calcium oxalate crystal formation in rat hyperoxaluric. Kidneys PLoS One 10(8):e0134764PubMedCrossRef Huang HS, Ma MC (2015) High sodium-induced oxidative stress and poor anticrystallization defense aggravate calcium oxalate crystal formation in rat hyperoxaluric. Kidneys PLoS One 10(8):e0134764PubMedCrossRef
21.
Zurück zum Zitat Fishman AI, Green D, Lynch A, Choudhury M, Eshghi M, Konno S (2013) Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation. Urology 82(2):1–7CrossRef Fishman AI, Green D, Lynch A, Choudhury M, Eshghi M, Konno S (2013) Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation. Urology 82(2):1–7CrossRef
22.
Zurück zum Zitat Lu X, Wang C, Liu B (2015) The role of Cu/Zn-SOD and Mn-SOD in the immune response to oxidative stress and pathogen challenge in the clam Meretrix meretrix. Fish Shellfish Immunol 42(1):58–65PubMedCrossRef Lu X, Wang C, Liu B (2015) The role of Cu/Zn-SOD and Mn-SOD in the immune response to oxidative stress and pathogen challenge in the clam Meretrix meretrix. Fish Shellfish Immunol 42(1):58–65PubMedCrossRef
23.
Zurück zum Zitat Pirinccioglu AG, Gökalp D, Pirinccioglu M et al (2010) Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clin Biochem 43(15):1220–1224PubMedCrossRef Pirinccioglu AG, Gökalp D, Pirinccioglu M et al (2010) Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clin Biochem 43(15):1220–1224PubMedCrossRef
24.
Zurück zum Zitat Chen L, Li Y, Yin W et al (2016) Combination of chlorogenic acid and salvianolic acid B protects against polychlorinated biphenyls-induced oxidative stress through Nrf2. Environ Toxicol Pharmacol 46:255–263PubMedCrossRef Chen L, Li Y, Yin W et al (2016) Combination of chlorogenic acid and salvianolic acid B protects against polychlorinated biphenyls-induced oxidative stress through Nrf2. Environ Toxicol Pharmacol 46:255–263PubMedCrossRef
25.
Zurück zum Zitat Zhao GR, Zhang HM, Ye TX et al (2008) Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol 46(1):73PubMedCrossRef Zhao GR, Zhang HM, Ye TX et al (2008) Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol 46(1):73PubMedCrossRef
26.
Zurück zum Zitat Pullar JM, Carr AC, Vissers MC (2013) Vitamin C supplementation and kidney stone risk. N Z Med J 126(126):133–134PubMed Pullar JM, Carr AC, Vissers MC (2013) Vitamin C supplementation and kidney stone risk. N Z Med J 126(126):133–134PubMed
27.
Zurück zum Zitat Hoffer LJ (2013) Ascorbic acid supplements and kidney stone risk. Jama Intern Med 173(14):1384PubMedCrossRef Hoffer LJ (2013) Ascorbic acid supplements and kidney stone risk. Jama Intern Med 173(14):1384PubMedCrossRef
28.
Zurück zum Zitat Tiselius HG (2010) New horizons in the management of patients with cystinuria. Curr Opin Urol 20(2):169–173PubMedCrossRef Tiselius HG (2010) New horizons in the management of patients with cystinuria. Curr Opin Urol 20(2):169–173PubMedCrossRef
Metadaten
Titel
Protective effect of salvianolic acid B against oxidative injury associated with cystine stone formation
verfasst von
Zhang Yifan
Xu Luwei
Liang Kai
Zhou Liuhua
Ge Yuzheng
Jia Ruipeng
Publikationsdatum
18.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 6/2019
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-019-01114-4

Weitere Artikel der Ausgabe 6/2019

Urolithiasis 6/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.